GENE ONLINE|News &
Opinion
Blog

HeFH
Verve Makes Successful Wall Street Debut on Back of its Promising Base Editor
2021-06-20
Verve Raises $94M in Series B, Aims to Disrupt Cardiology Market with ‘Once-and-Done’ Gene Editing Therapies
2021-01-21
Spotlight: Cholesterol Reducing Drugs Could Potentially Augment Cancer Immunotherapy
2020-11-22
Regeneron’s Antibody Therapy Reduces LDL Cholesterol in Hypercholesterolemia Patients
2020-11-21
Amgen to Serve Japanese Healthcare Market with Complete Ownership of 7 Year Joint Venture
2020-04-01
FDA Approval of Cholesterol Lowering Drug, NEXLETOL, A Value-Add to Existing Treatments
2020-02-25
LATEST
Accelerated Bio and Pluristyx Generate Clinical-Grade Induced Pluripotent Stem Cells from Reprogrammed Human Trophoblast Stem Cells
2024-07-12
Novo Nordisk and PT Bio Farma Agree to Enhance Insulin Production for Diabetes Patients in Indonesia
2024-07-12
Alzheimer’s Drug LEQEMBI Approved for Treatment in Hong Kong
2024-07-12
Foreseen Biotech Strikes $1.03B Deal with Ipsen for First-in-Class ADC
2024-07-12
Synthetic Biology’s Innovator Dr. John Cumbers – Addressing Inefficiencies in Biopharma and Economic Sustainability
2024-07-11
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
2024-07-11
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
2024-07-11
EVENT
Scroll to Top